Generic drugmaker Aurobindo Pharma is recalling 4,608 bottles of pain relieving drug Acetaminophen Tablets, 325 mg, in the U.S.
They are 100-count bottles and being recalled due to deviations from current Good Manufacturing Practices (cGMP), the U.S. Food and Drug Administration (U.S. FDA) said. Specially it is “due to confirmed consumer complaints received with the observation of tablet discoloration (brown surface on tablets),” the regulator said in its latest enforcement report.
It is a voluntary recall and initiated by Aurobindo Pharma USA Inc., a subsidiary of the Hyderabad-based drugmaker, on May 22.
Published – June 27, 2025 09:18 pm IST